The Association of the Use of Opioid and Psychotropic Medications With Workers' Compensation Claim Costs and Lost Work Time

Journal of Occupational and Environmental Medicine

Volumn 57, Issue 2, 2015, Pages 196-201

  Tao, Xuguang ^a   Lavin, Robert A ^b   Yuspeh, Larry ^c   Weaver, Virginia M ^d   Bernacki, Edward J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Louisiana Workers' Compensation Corporation   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OPIATE; PSYCHOTROPIC AGENT; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT; SHORT ACTING ANALGESIC AGENT;

ARTICLE; DISEASE DURATION; DRUG COST; HUMAN; PRESCRIPTION; RETURN TO WORK; TREATMENT DURATION; WORK DISABILITY; WORKMAN COMPENSATION; ECONOMICS; MEDICAL LEAVE; OCCUPATIONAL ACCIDENT; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; ANALGESICS, SHORT-ACTING; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DRUG PRESCRIPTIONS; HUMANS; HYPNOTICS AND SEDATIVES; OCCUPATIONAL INJURIES; PSYCHOTROPIC DRUGS; SICK LEAVE; WORKERS' COMPENSATION;

EID: 84930518767     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000333     Document Type: Article

References (40)

1. Bernacki EJ, Yuspeh L, Lavin R, Tao XG. Increases in the use and cost of opioids to treat acute and chronic pain in injured workers, 1999 to 2009. J Occup Environ Med. 2012;54:216-223.
2. Lavin RA, Tao X, Yuspeh L, Bernacki EJ. Temporal relationship between lumbar spine surgeries, return to work, and workers' compensation costs in a cohort of injured workers. J Occup Environ Med. 2013;55:539-543.
3. Tao XG, Lavin RA, Yuspeh L, Bernacki EJ. Impact of the combined use of opioids and surgical procedures on workers' compensation cost among a cohort of injured workers in the State of Louisiana. J Occup Environ Med. 2012;54:1513-1519.
4. Tao XG, Lavin RA, Yuspeh L, Bernacki EJ. Natural history of opioid dosage escalation post-injury: a cohort study of injured workers in the State of Louisiana. J Occup Environ Med. 2012;54:439-444.
5. Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am. 2009;91:919-927.
6. Franklin GM, Rahman EA, Turner JA, Daniell WE, Fulton-Kehoe D. Opioid use for chronic low back pain: a prospective, population-based study among injured workers in Washington state, 2002-2005. Clin J Pain. 2009;25:743-751.
7. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26:1-8.
8. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138:440-449.
9. Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776-1782.
10. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613-2620.
11. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657-659.
12. Cerda M, Ransome Y, Keyes KM, et al. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013;132:53-62.
13. Green TC, Grau LE, Carver HW, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug Alcohol Depend. 2011;115:221-228.
14. Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84:613-624.
15. Yaksh T, Wallace M. Chapter 18. Opioids, analgesia, and pain management. In: Brunton LL, Chabner BA, Knollmann BC. eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e. New York, NY: McGraw-Hill; 2011.
16. Manchikanti L, Manchukonda R, Pampati V, Damron KS. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician. 2005;8:257-261.
17. Bernacki EJ, Tao XG. The relationship between attorney involvement, claim duration, and workers' compensation costs. J Occup Environ Med. 2008;50:1013-1018.
18. Tao XG, Lavin RA, Yuspeh L, Bernacki EJ. Implications of lumbar epidural steroid injections after lumbar surgery. J Occup Environ Med. 2014;56:195-203.
19. SAS [computer program]. Version 9.3: SAS. Cary, NC: Institution Inc; 2010.
20. Wang D. Longer-Term Use of Opioids. 2nd ed. Cambridge, MA: WCRI; 2014.
21. Berecki-Gisolf J, Collie A, McClure RJ. Prescription opioids for occupational injury: results from workers' compensation claims records. Pain Med. 2014;15:1549-1557.
22. Wang D, Muellwe K, Hashimoto D. Interstate Variations in Use of Narcotics. Cambridge, MA: WCRI; 2011.
23. Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307:940-947.
24. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087-2093.
25. Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007;23:307-315.
26. Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31:564-570.
27. Sullivan MD, Howe CQ. Opioid therapy for chronic pain in the United States: promises and perils. Pain. 2013;154(suppl 1):S94-S100.
28. Belleville G. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. Can J Psychiatry. 2010;55:558-567.
29. Cooper ZD, Truong YN, Shi YG, Woods JH. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. J Pharmacol Exp Ther. 2008;326:920-929.
30. Schubert I, Ihle P, Sabatowski R. Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data. Dtsch Arztebl Int. 2013;110:45-51.
31. Guck TP, Meilman PW, Skultety FM, Dowd ET. Prediction of long-term outcome of multidisciplinary pain treatment. Arch Phys Med Rehabil. 1986;67:293-296.
32. Dillie KS, Fleming MF, Mundt MP, French MT. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med. 2008;21:108-117.
33. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125:172-179.
34. Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM. Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort. Spine (Phila Pa 1976). 2008;33:199-204.
35. Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine (Phila Pa 1976). 2007;32:2127-2132.
36. Sjogren P, Gronbaek M, Peuckmann V, Ekholm O. A population-based cohort study on chronic pain: the role of opioids. Clin J Pain. 2010;26:763-769.
37. Volinn E, Fargo JD, Fine PG. Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. Pain. 2009;142:194-201.
38. Hinkel N. Learning the list. The Preferred Drug List and how it works. J Ark Med Soc. 2004;101:168-170.
39. Robst JM, Constantine R, Boaz T, et al. Short-term impact of preferred drug list changes on health care use and Medicaid costs: injectable risperidone. Psychiatr Serv. 2010;61:937-939.
40. Park SK. Exploration of the prevalence and correlates of depression among South Korean workers with injuries. Work. 2011;39:345-351.